LUNGENVERSAGEN
Conditions
Interventions
Group 1: In 11 patients with COVID-19 associated ARDS and 11 patients with non-COVID-19 associated ARDS, in whom intermittent prone positioning is intended as a therapeutic option, the regional ventil
Sponsors
Anästhesiologische Universitätsklinik Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: prone positioning-therapy in patients in COVID-19 associated or non-COVID-19 associated ARDS
Exclusion criteria
Exclusion criteria: Age NYHA 2, acute right heart failure, therapy with inhaled NO, ECMO, contraindications for EIT measurements (active implants, eg. pacemaker, cardioverter), BMI = 35 kg*m-2, traumatic brain injury, or intracerebral hemorrhage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Index of oxygenation (paO2/FiO2) | — |
Secondary
| Measure | Time frame |
|---|---|
| Homogenity of regional ventilation | — |
Countries
Germany
Contacts
Public ContactStefan Schumann
Anästhesiologische Universitätsklinik Freiburg
Outcome results
None listed